电沉积 LEU UO2 靶件生产医用99Mo的工艺研究
Development of Simulated Process for Medical Fission 99Mo Production Using Electroplating UO2 Target with Low Enriched Uranium
-
摘要: 99Mo是一种重要的医用放射性同位素。采用低浓铀(LEU)靶件生产裂变99Mo是发展趋势。本工作进行了电沉积UO2靶件制备、靶件溶解以及99Mo化学分离等工艺研究,确定了电沉积LEU UO2靶件制备医用裂变99Mo的工艺流程。研究表明,于不锈钢管内壁上电沉积UO2,在pH=7、电流0.5~2 mA/cm2、温度75~90 ℃、镀液中U浓度5 mg/mL条件下,经过约210 h电沉积,不锈钢管内壁上UO2沉积层质量达到42 mg/cm2;采用6 mol/L HNO3溶解UO2镀层。采用α-安息香肟沉淀法实现99Mo与大量裂变产物的初步分离,采用阴离子交换法与活性炭色层法联用实现99Mo的纯化;纯化后的99Mo溶液中,杂质131I、90Sr、95Zr、103Ru、238U活度与99Mo活度比值分别为4.47×10-6%、7.40×10-7%、8.67×10-7%、2.57×10-6%、1.69×10-14%,均小于《欧洲药典》规定值,满足医用要求。本工作建立了电沉积LEU UO2靶件生产高纯医用裂变99Mo的工艺流程,为今后采用LEU技术生产医用裂变99Mo,进而实现其自主规模化生产打下了基础。Abstract: 99Mo is a kind of important medical radioisotope in nuclear medicine. Conversion from high enriched uranium (HEU) to low enriched uranium (LEU) is a trend for fission 99Mo production. In this study, the whole production procedure of fission 99Mo had been developed with an emphasis on LEU target by electroplating UO2 layer on inner wall of a hollow stainless cylinder, dissolution procedure of UO2 target with heated 6 mol/L HNO3 solution and radiochemical extraction process of fission 99Mo from simulated solution by α-benzoin oxime precipitation, followed by AG1×8 anion exchange and activated charcoal chromatography for further purification. For UO2 target preparation, optimum parameters for electrodeposition were as follows: 5 mg/mL of uranium concentration, pH=7, 0.5-2 mA/cm2 of current density and the temperature of 75-90 ℃. After about 210 hours of electroplating, the resulting film thickness was 42 mg/cm2 UO2 on the inner surface of the tube. In the final 99Mo solution, the ratios of the radioactivity of impurities such as 131I, 90Sr, 95Zr, 103Ru, 238U to that of 99Mo are 4.47×10-6%, 7.40×10-7%, 8.67×10-7%, 2.57×10-6%, and 1.69×10-14% respectively that are less than those specified in European Pharmacopoeia, indicating that 99Mo purified by the established processing procedure in this work can meet the requirements for medical usage. This work will be expected to pave the way for fission 99Mo production at a large scale with LEU target.
-
Keywords:
- fission 99Mo /
- LEU /
- electroplating UO2 target /
- 99Mo production process
-
-
[1] OECD-NEA (2017). The supply of medical radioisotopes: 2017 medical isotope supply review:99Mo/99mTc market demand and production capacity projection 2017-2022[EB/OL]. [2018-03-09]. www.oecd-nea.org. [2] Arino H, Kramer H, McGovern J, et al. Production of high purity fission product 99Mo: US, US 3 799 883A[P]. 1974. [3] Walt T, Coetzee P. The isolation of 99Mo from fission material for use in the 99Mo/99mTc generator for medical use[J]. Radiochimica Acta,2004, 92(04): 251-257. [4] McDonald M J, Carson S D, Naranjo G E, et al,Challenges of extracting and purifying fission-produced molybdenum-99[J]. Industrial Engineering Chemistry Research, 2000, 39, 3146-3150. [5] Dadachova K, Riviere K, Anderson P. Improved processes of 99Mo production[J]. Journal of Radioanalytical and Nuclear Chemistry, 1999, 240(03): 935-938. [6] Hwang D, Choung W, Kim Y, et al. Separation of 99Mo from a simulated fission product solution by precipitation with α-benzoin oxime[J]. Journal of Radioanalytical and Nuclear Chemistry, 2002, 254(02): 255-262. [7] 王清贵,梁积新,吴宇轩,等. α-安息香肟沉淀法分离低浓铀裂变产物中的钼[J]. 同位素,2016,29(3):216-222.Wang Qinggui, Liang Jixin, Wu Yuxuan, et al. Separation of fission molybdenum from low enriched uranium products by precipitation with αBenzoin Oxime[J]. Journal of Isotopes, 2016, 29(3): 216-222(in Chinese). [8] Bernhard G. Separation of radionuclides from a fission product solution by ion exchange on alumina[J]. Journal of Radioanalytical and Nuclear Chemistry, 1994, 177(02): 321-325. [9] Lee S K, Beyer G J, Lee J S. Development of industrial scale fission 99Mo production process using low enriched uranium target[J]. Nuclear Engineering and Technology, 2016, 48: 613-623. [10] IAEA-TECDOC-515. Fission molybdenum for medical use[R]. Vienna: IAEA, 1989. [11] The Eruopean Directorate for the Quality of Medicines & Healthcare Strasbourg. Sodium molybdate (99Mo) solution (fission), European Pharmacopoeia 8th edition[R]. France: EDQM, 2013: 1088-1089.
计量
- 文章访问数: 524
- HTML全文浏览量: 0
- PDF下载量: 568